Crossmark Global Holdings’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.31M Buy
12,821
+1,862
+17% +$480K 0.05% 319
2025
Q1
$2.45M Buy
10,959
+4,116
+60% +$921K 0.04% 373
2024
Q4
$1.57M Sell
6,843
-891
-12% -$204K 0.03% 458
2024
Q3
$1.89M Sell
7,734
-499
-6% -$122K 0.03% 431
2024
Q2
$1.58M Sell
8,233
-228
-3% -$43.6K 0.03% 460
2024
Q1
$1.68M Sell
8,461
-84
-1% -$16.6K 0.03% 471
2023
Q4
$1.47M Sell
8,545
-538
-6% -$92.6K 0.03% 485
2023
Q3
$1.37M Sell
9,083
-1,114
-11% -$168K 0.03% 486
2023
Q2
$2.28M Buy
10,197
+323
+3% +$72.1K 0.05% 377
2023
Q1
$2.16M Sell
9,874
-391
-4% -$85.6K 0.05% 382
2022
Q4
$2.14M Buy
10,265
+1,500
+17% +$312K 0.05% 377
2022
Q3
$1.91M Sell
8,765
-63
-0.7% -$13.8K 0.05% 373
2022
Q2
$1.85M Buy
8,828
+160
+2% +$33.5K 0.05% 402
2022
Q1
$2.1M Buy
8,668
+350
+4% +$84.9K 0.05% 397
2021
Q4
$2.17M Sell
8,318
-4,690
-36% -$1.22M 0.05% 384
2021
Q3
$3.43M Sell
13,008
-650
-5% -$171K 0.08% 257
2021
Q2
$3.37M Sell
13,658
-1,040
-7% -$256K 0.08% 258
2021
Q1
$2.85M Sell
14,698
-1,130
-7% -$219K 0.07% 284
2020
Q4
$3.36M Buy
15,828
+3,041
+24% +$646K 0.09% 262
2020
Q3
$2.19M Sell
12,787
-1,054
-8% -$181K 0.06% 319
2020
Q2
$2.66M Sell
13,841
-621
-4% -$119K 0.08% 273
2020
Q1
$2.13M Sell
14,462
-80
-0.6% -$11.8K 0.08% 275
2019
Q4
$2.25M Buy
14,542
+2,258
+18% +$350K 0.06% 333
2019
Q3
$1.66M Sell
12,284
-93,605
-88% -$12.6M 0.05% 409
2019
Q2
$12.9M Sell
105,889
-1,827
-2% -$223K 0.36% 59
2019
Q1
$11.2M Buy
107,716
+332
+0.3% +$34.5K 0.32% 71
2018
Q4
$12.2M Sell
107,384
-7,058
-6% -$804K 0.38% 57
2018
Q3
$13.2M Buy
114,442
+3,142
+3% +$362K 0.34% 61
2018
Q2
$11.5M Buy
111,300
+4,207
+4% +$436K 0.31% 69
2018
Q1
$10.5M Sell
107,093
-789
-0.7% -$77.7K 0.27% 83
2017
Q4
$9.14M Buy
107,882
+8,939
+9% +$757K 0.22% 113
2017
Q3
$7.62M Buy
+98,943
New +$7.62M 0.2% 126
2016
Q3
$7.62M Buy
+98,943
New +$7.62M 0.2% 126